In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Ivax buys generics company Zenith Laboratories

Executive Summary

Medical and chemical holding company Ivax is buying Zenith Laboratories (generics) for about $600 million in Ivax stock (1.307 Ivax common shares for each Zenith share). The acquisition creates the world's largest generics company. 12/94: finalized.
Deal Industry
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition

Related Companies